Insights
The science behind biology-led discovery
Explore our publications, scientific perspectives, corporate information and announcements on the development and application of the Intellomx platform.
Featured white paper
REVEALING CAUSAL BIOLOGY TO TRANSFORM DRUG DISCOVERY — Our explanation of the rationale for causal biology, the I³ approach, target-to-drug integration and selected case study examples.
Company overview
INTELLOMX CORPORATE PRESENTATION 2026 — A non-confidential introduction to the platform, research programmes and partnering opportunities.
News and announcements
Read our latest collaboration announcements, platform developments and company news, including the publicly announced Johnson & Johnson target discovery programmes.
Scientific publications
Find selected peer-reviewed papers and scientific abstracts relevant to the research underpinning Intellomx and its collaborators. Individual records should identify authors, journal, date and a link to the original publication.
Have a scientific question?
For a deeper discussion of our approach or its application to your programme, our team welcomes enquiries from pharmaceutical and biotechnology scientists and business-development leaders.